Chapitre 5: Le traitement de la tuberculose active-Reference-Cited by-同舟云学术

Chapitre 5: Le traitement de la tuberculose active

Published:2023-11-02 Issue:6 Volume:7 Page:342-353
ISSN:2474-5332
Container-title:Canadian Journal of Respiratory, Critical Care, and Sleep Medicine
language:en
Short-container-title:Canadian Journal of Respiratory, Critical Care, and Sleep Medicine

Author:

Johnston James C.¹²^ORCID,Cooper Ryan³,Menzies Dick⁴

Affiliation:

1. Division de pneumologie de l’Université de la Colombie-Britannique, Vancouver, Colombie-Britannique, Canada

2. British Columbia Centre for disease Control, Vancouver, Colombie-Britannique, Canada

3. Division des maladies infectieuses, Université de l’Alberta, Royal Alexandra Hospital, Edmonton, Alberta, Canada

4. Département de médecine, d’épidémiologie et de biostatistique de l’Université McGill, Montréal, Québec, Canada

Publisher

Informa UK Limited

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/24745332.2023.2226003

Reference67 articles.

1. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis

2. Organisation mondiale de la Santé. Guidelines for treatment of drug-susceptible tuberculosis and patient care mise à jour de 2017. 2017. License: CC BY-NC-SA 3.0 IGO.

3. Effect of Intermittency on Treatment Outcomes in Pulmonary Tuberculosis: An Updated Systematic Review and Metaanalysis

4. Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis

5. Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective